Life Sciences

The Worcester incubator received a $375,000 grant from one of its successful graduate companies toward MBI’s $6-million goal to build out a biomanufacturing center.

Arch Therapeutics, a Framingham-based company specializing in wound care and biosurgical products, raised $2.6 million in bridge funding ahead of an intended uplisting of company stock.

KARL STORZ Endoscopy-America, a medical technology manufacturer based in California, signed a new lease expanding from 140,000 square feet of space to 225,629 square feet at its 28 Millbury St. facility in Auburn.

The life sciences industry in Massachusetts experienced growth in 2022 in employment, total jobs, and continues to bring in venture capital dollars.

Mary Munson, a UMass Chan Medical School professor, is an accomplished scientist and a champion for women in science.

Natick-based Aleta Biotherapeutics, a cancer treatment development company, has received clearance from the U.K. Medicines and Healthcare products Regulatory Agency to investigate a new therapeutic for lymphoma in a clinical trial.

Marlborough-based biotechnology and manufacturing firm Boston Scientific has received U.S. Food and Drug Administration approval for a new catheter system for patients with atrial fibrillation, which is a type of abnormal heartbeat.

Marlborough-based drug manufacturer TheracosBio has named Brian Connelly as its new president and CEO.

Marlborough-based Boston Scientific plans to construct a new facility in Maple Grove, Minnesota, a spokesperson for the biotechnology and manufacturing company confirmed Thursday.

Seeing growth in the number of construction projects in Central Massachusetts, Canton-based Timberline Construction Corp. opened its second location in June with an office inside the One Mercantile office complex.